Trial intelligence / Profile preview

Tardyferon for Fatigue in Iron-Deficient Blood Donors

NCT00689793Phase 4Completed

Sponsor
University of Lausanne
Start
Nov 2008
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Tardyferon with Placebo (2 arms). Primary endpoint: Level of Fatigue at 4 weeks. Started Nov 2008; status: completed.

02

Drugs

ferrous sulfate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT00689793.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00689793.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call